Our previous studies show that ERRα performs oncogenic roles in the advanced growth of prostate cancer via its promotion of hypoxia growth adaptation 21 and also transcriptional regulation of TMPRSS2:ERG fusion gene 18. The gene discussed is ESRRA; the disease is prostate cancer.